Endoscopic Postoperative Recurrence In Crohn's Disease After Curative Ileocecal Resection With Early Prophylaxis By Anti-Tnf, Vedolizumab Or Ustekinumab A Real-World Multicenter Eu...

Yanai Henit, Kagramanova Anna, Knyazev Oleg, Sabino João, Haenen Shana, Mantzaris Gerassimos J., Mountaki Katerina, Armuzzi Alessandro, Pugliese Daniela, Furfaro Federica, Fiorino Gionata, Drobne David, Farkas Klaudia, Molnár Tamás, Bacsur Péter, et al
2022

Effectiveness of Third-Class Biologic Treatment in Crohn's Disease

Albshesh Ahmad, Taylor Joshua, Savarino Edoardo V., Truyens Marie, Armuzzi Alessandro, Ribaldone Davide G., Bar-Gil Shitrit Ariella, Fibelman Morine, Molander Pauliina, Liefferinckx Claire, Nancey Stephane, Korani Mohamed, Rutka Mariann, Barreiro-de Acosta Manuel, Molnár Tamás
2021

Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases A European retrospective observational study /

Goessens Laurent, Colombel Jean-Frédéric, Outtier An, Ferrante Marc, Sabino Joao, Judge Ciaran, Saeidi Reza, Rabbitt Louise, Armuzzi Alessandro, Domenech Eugeni, Michalopoulos George, Molnár Tamás, Gecse Krisztina, Farkas Klaudia, Kollaborációs szervezet: European COMBIO study group, Resál Tamás
2021

I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease

Peyrin-Biroulet Laurent, Rahier Jean-François, Kirchgesner Julien, Abitbol Vered, Sebastian Shaji, Armuzzi Alessandro, Karmiris Konstantinos, Gisbert Javier P., Bossuyt Peter, Helwig Ulf, Burisch Johan, Yanai Henit, Glen A. Doherty, Molnár Tamás, Kollaborációs Szervezet: I-CARE Collaborator Group
2023